Conflicts of interest B.S. with Amgen, Wyeth Pharmaceuticals, Abbott Labs, Astellas, Centocor and Genentech; C.T. with Amgen, Abbott Labs, Genentech and Connetics; P.Y. with Amgen, Abbott Labs, Astellas, Genentech and Centocor; J.L.M. with Amgen, Genentech, Biogen, Steiffel and Abbott; M.H., Y-C.Y. with Amgen, and has Amgen stock and stock options; F.D. was fomerly with Amgen, and has Amgen stock and options.
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
Article first published online: 22 MAY 2008
© 2008 The Authors. Journal Compilation © 2008 British Association of Dermatologists
British Journal of Dermatology
Volume 159, Issue 2, pages 322–330, August 2008
How to Cite
Strober, B., Teller, C., Yamauchi, P., Miller, J.L., Hooper, M., Yang, Y.-C. and Dann, F. (2008), Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. British Journal of Dermatology, 159: 322–330. doi: 10.1111/j.1365-2133.2008.08628.x
- Issue published online: 17 JUL 2008
- Article first published online: 22 MAY 2008
- Accepted for publication 11 February 2008
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.